A plan that covers preventive visits, diagnostic exams, and any necessary treatments can make it easier to stay on top of your oral health
Earlier this month, (June 2025), Novo inked a deal worth up to $815 million with Deep Apple Therapeutics, a South San Francisco-based company specializing in small-molecule drug discovery to discover, develop, and commercialize oral small-molecule therapeutics directed at a non-incretin G protein-coupled receptors (GPCR) target for cardiometabolic diseases, including obesity, in a deal worth up to $812 million
TRIUMPH-1 Phase 3 Trial Results Drawing attention to its efficiency, the TRIUMPH-1 Phase 3 trial showcased remarkable weight loss achievements
However, using the correct amount of solvent is crucial for accurate dosing in your research
DOSY analysis Diffusion-ordered 2D NMR spectroscopy (DOSY) was used to investigate the oligomerization state of PGRMC1 (a.a.44195) induced by haem binding